» Articles » PMID: 38894518

Skeletal Phenotypes and Molecular Mechanisms in Aging Mice

Overview
Journal Zool Res
Publisher Science Press
Date 2024 Jun 19
PMID 38894518
Authors
Affiliations
Soon will be listed here.
Abstract

Aging is an inevitable physiological process, often accompanied by age-related bone loss and subsequent bone-related diseases that pose serious health risks. Research on skeletal diseases caused by aging in humans is challenging due to lengthy study durations, difficulties in sampling, regional variability, and substantial investment. Consequently, mice are preferred for such studies due to their similar motor system structure and function to humans, ease of handling and care, low cost, and short generation time. In this review, we present a comprehensive overview of the characteristics, limitations, applicability, bone phenotypes, and treatment methods in naturally aging mice and prematurely aging mouse models (including , mutant, , , , , , , and -deficient mice). We also summarize the molecular mechanisms of these aging mouse models, including cellular DNA damage response, senescence-related secretory phenotype, telomere shortening, oxidative stress, bone marrow mesenchymal stem cell (BMSC) abnormalities, and mitochondrial dysfunction. Overall, this review aims to enhance our understanding of the pathogenesis of aging-related bone diseases.

References
1.
Lei Y, Martinez C, Torres-Odio S, Bell S, Birdwell C, Bryant J . Elevated type I interferon responses potentiate metabolic dysfunction, inflammation, and accelerated aging in mtDNA mutator mice. Sci Adv. 2021; 7(22). PMC: 8153723. DOI: 10.1126/sciadv.abe7548. View

2.
Wang J, Clauson C, Robbins P, Niedernhofer L, Wang Y . The oxidative DNA lesions 8,5'-cyclopurines accumulate with aging in a tissue-specific manner. Aging Cell. 2012; 11(4):714-6. PMC: 3399950. DOI: 10.1111/j.1474-9726.2012.00828.x. View

3.
Almeida M, Ambrogini E, Han L, Manolagas S, Jilka R . Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. J Biol Chem. 2009; 284(40):27438-48. PMC: 2785673. DOI: 10.1074/jbc.M109.023572. View

4.
Gregg S, Robinson A, Niedernhofer L . Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease. DNA Repair (Amst). 2011; 10(7):781-91. PMC: 3139823. DOI: 10.1016/j.dnarep.2011.04.026. View

5.
Levin V, Jiang X, Kagan R . Estrogen therapy for osteoporosis in the modern era. Osteoporos Int. 2018; 29(5):1049-1055. DOI: 10.1007/s00198-018-4414-z. View